Global dual chamber prefilled syringes market is estimated to be valued at USD 171.8 Mn in 2024, and is expected to reach USD 281.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031.
Key Takeaways
Key players operating in the dual chamber prefilled syringes are Pfizer Inc., NIPRO PHARMA CORPORATION, Gerresheimer AG, Vetter Pharma, Credence MedSystems, Inc., ARTE Corporation, BD, MAEDA INDUSTRY Co., Ltd., Bayer, Stevanato Group, Elcam Drug Delivery Devices, SCHOTT Pharma, OndrugDelivery Ltd, Catalent, Inc, Dauml;twyler Holding Inc. Rising demand for user-friendly drug delivery devices along with the growth of injectable drug formulations like biologics have positively impacted the dual chamber prefilled syringes market. The market players are expanding their manufacturing and distribution facilities globally to cater to the growing requirements of pharmaceutical companies for dual chamber prefilled syringes.
Key players operating in the Dual Chamber Prefilled Syringes Market Size are focusing on capacity expansion activities and product launches to capitalize on the lucrative opportunities. The demand for dual chamber prefilled syringes is increasing across major markets like North America, Europe, Asia Pacific due to the growing geriatric population suffering from chronic diseases such as diabetes, cancer, and autoimmune disorders. Pharmaceutical companies are preferring dual chamber prefilled syringes over traditional delivery forms owing to their convenience and improved efficacy of drug delivery. Major players are also engaging in collaborations with biosimilar and generic drug developers to expand the customer base.
Market Drivers
The rising use of self-administered drug delivery systems is a key factor propelling the dual chamber prefilled syringes market growth. Dual chamber prefilled syringes allow for easy and accurate reconstitution of drugs without requiring any specialized skills. They prove highly beneficial for administering different formulations like dry liquid components and also reduce medication errors. Increased funding by governments and pharmaceutical giants for the development of biologics will further accentuate the demand for dual chamber prefilled syringes as their airtight design helps preserve drug stability. Stringent regulatory standards regarding delivery devices and innovative product launches by leading manufacturers are also creating a positive outlook for the dual chamber prefilled syringes industry.
The current geopolitical situation is impacting the growth of the Dual Chamber Prefilled Syringes Market in several ways. The ongoing Russia-Ukraine conflict and sanctions on Russia have disrupted supply chains and trade flows. This has led to increased raw material costs and delays in procurement of components for dual chamber prefilled syringes manufacturing. The conflict has also exacerbated existing inflationary pressures caused by the COVID-19 pandemic. High inflation is affecting the purchasing power of consumers and their ability to afford expensive drugs administered through prefilled syringes. Additionally, the diversion of healthcare resources towards addressing the humanitarian crisis arising from the conflict is reducing investments in new drug development and production of prefilled syringes
Get more insights on Dual Chamber Prefilled Syringes market